SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 14, 1996
OSTEOTECH, INC.
---------------
(Exact name of registrant as specified in its charter)
Delaware 0-19278 13-3357370
-------- ------- ----------
State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification)
51 James Way, Eatontown, New Jersey 07724
- ----------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (908) 542-2800
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events
On November 14, 1996, the Company announced that it had
introduced Grafton (registered trademark) Demineralized Bone Matrix (DBM) Putty,
a major new proprietary form of human demineralized bone. Grafton Putty
complements Grafton DBM Flex which was introduced in January, 1996 and Grafton
DBM Gel which has been on
the market since late 1991.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Dated: November 14, 1996
OSTEOTECH, INC.
(Registrant)
By: /S/ MICHAEL J. JEFFRIES
Michael J. Jeffries
Executive Vice President,
Chief Operating Officer
and Chief Financial
Officer (Principal
Financial Officer
and Principal Accounting
Officer)
